Evidence map›Paper›PMID 29884810›Full record

ArticleScientific reports2018

Intraoperative detection of circulating tumor cells in pulmonary venous blood during metastasectomy for colorectal lung metastases.

Uyen-Thao Le, Peter Bronsert, Francesco Picardo, Sabine Riethdorf, Benedikt Haager, Bartosz Rylski, Martin Czerny, Friedhelm Beyersdorf, Sebastian Wiesemann, Klaus Pantel and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Biological factors driving colorectal cancer metastasis.World journal of gastrointestinal oncology · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Circulating tumor cells in colorectal cancer in the era of precision medicine.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Uyen-Thao LeDepartment of Thoracic Surgery, Medical Center - University of Freiburg, Freiburg, Germany.
Peter BronsertInstitute for Surgical Pathology, Medical Center - University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0001-8558-0347
Francesco PicardoLaboratory of Molecular Medicine and Biotechnology, Campus Bio-Medico University of Rome, Rome, Italy.
Sabine RiethdorfInstitute for Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Benedikt HaagerDepartment of Thoracic Surgery, Medical Center - University of Freiburg, Freiburg, Germany.
Bartosz RylskiDepartment of Cardiovascular Surgery, University Heart Center Freiburg, Freiburg, Germany.
Martin CzernyDepartment of Cardiovascular Surgery, University Heart Center Freiburg, Freiburg, Germany.
Friedhelm BeyersdorfDepartment of Cardiovascular Surgery, University Heart Center Freiburg, Freiburg, Germany.
Sebastian WiesemannDepartment of Thoracic Surgery, Medical Center - University of Freiburg, Freiburg, Germany.
Klaus PantelInstitute for Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bernward PasslickDepartment of Thoracic Surgery, Medical Center - University of Freiburg, Freiburg, Germany.
Jussuf Thomas KaifiSection for Thoracic Surgery, Hugh E. Stephenson Jr., MD, Department of Surgery, Ellis Fischel Cancer Center, University of Missouri, Columbia, USA.
Severin SchmidDepartment of Thoracic Surgery, Medical Center - University of Freiburg, Freiburg, Germany. severin.schmid@uniklinik-freiburg.de.ORCID http://orcid.org/0000-0001-8077-082X
University of Freiburg · DEUniversität Hamburg · DEUniversità Campus Bio-Medico · ITUniversity of Missouri · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor cells (CTC) have been studied extensively in various tumor types and are a well-established prognosticator in colorectal cancer (CRC). This is the first study to isolate CTC directly from the tumor outflow in secondary lung tumors. For this purpose in 24 patients with CRC who underwent pulmonary metastasectomy in curative intent blood was drawn intraoperatively from the pulmonary vein (tumor outflow). In 22 samples CTC-enumeration was performed using CellSieve-microfilters and immunohistochemical- and Giemsa-staining. Additionally 10 blood samples were analyzed using the CellSearch-System. We could isolate more CTC in pulmonary venous blood (total 41, range 0-15) than in samples taken from the periphery at the same time (total 6, range 0-5, p = 0.09). Tumor positive lymph nodes correlated with presence of CTC in pulmonary venous blood as in all cases CTC were present (p = 0.006). Our findings suggest a tumor cell release from pulmonary metastases in CRC and a correlation of CTC isolated from the tumor outflow with established negative prognostic markers in metastasized CRC. The presented data warrant further investigations regarding the significance of local tumor compartments when analyzing circulating markers and the possibility of tumor cell shedding from secondary lung tumors.

Indexed as

AdultAgedAged, 80 and overColorectal NeoplasmsFemaleHumansIntraoperative CareLung NeoplasmsMaleMetastasectomyMiddle AgedNeoplastic Cells, Circulating

Identifiers

PMID29884810
PMCPMC5993733
OpenAlexW2806195669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.